Literature DB >> 32808240

Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults.

Erik Puchon1, Maria Goboova2, Ivan Vano2, Tomas Fazekas3, Zuzana Javorova-Rihova1,4, Magdalena Kuzelova5.   

Abstract

PURPOSE: To investigate the relationship between medications with a known risk of gastrointestinal bleeding and proton pump inhibitor (PPI) prescription not according to guidelines.
METHODS: An analysis of the records of 592 hospitalised patients aged 65 years or older was undertaken. The number of all medicines, potentially inappropriate medicines according to the EU(7)-PIM list and the Beers Criteria 2019 and medicines with a known risk of gastrointestinal bleeding, was compared in patients with PPI prescription not given based on guidelines and in patients with no PPI prescription.
RESULTS: Patients prescribed PPI not based on guidelines used more medications on average (9.6 vs. 6.4, p < 0.001), more PIMs according to the EU(7)-PIM list (2.4 vs. 1.1, p < 0.001) and the Beers criteria (2.0 vs. 0.6, p < 0.001) at hospital admission and at discharge (8.9 vs. 7.5, p < 0.001, mean number of medications), (2.0 vs. 1.2, p < 0.001, EU(7)-PIM list), (1.9 vs. 0.8, p < 0.001, Beers criteria) than patients with no PPI prescription. Patients prescribed PPI not according to guidelines were more frequently using direct oral anticoagulants (28% vs. 12.8%, p < 0.001), corticosteroids (5.3% vs. 0.7%, p = 0.025) at hospital admission and at discharge (25.9% vs. 16.5%, p = 0.018, oral anticoagulants), (6.6% vs. 1%, p = 0.006, corticosteroids), (13.3% vs. 5.4%, p = 0.004, warfarin) than patients with no PPI prescription.
CONCLUSION: The number of medications, potentially inappropriate medications according to the EU(7)-PIM list and Beers criteria, and the use of direct oral anticoagulants, warfarin and corticosteroid prescriptions were the medication-related factors associated with PPI prescription not according to guidelines in elderly patients.

Entities:  

Keywords:  Guidelines; Medications; Older patients; Proton pump inhibitors; Slovak Republic

Year:  2020        PMID: 32808240     DOI: 10.1007/s41999-020-00380-5

Source DB:  PubMed          Journal:  Eur Geriatr Med        ISSN: 1878-7649            Impact factor:   1.710


  7 in total

1.  Prescription of proton pump inhibitors in older adults with complex polytherapy.

Authors:  Clara Cena; Sara Traina; Beatrice Parola; Mario Bo; Riccardo Fagiano; Carlotta Siviero
Journal:  Eur J Hosp Pharm       Date:  2019-03-16

2.  Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?

Authors:  Camille Lenoir; Myriam El Biali; Christophe Luthy; Olivier Grosgurin; Jules Alexandre Desmeules; Victoria Rollason
Journal:  Int J Clin Pharm       Date:  2019-10-29

3.  Study protocol for a single-centre, prospective, non-blinded, randomised, 12-month, parallel-group superiority study to compare the efficacy of pharmacist intervention versus usual care for elderly patients hospitalised in orthopaedic wards.

Authors:  Junpei Komagamine; Kenichi Sugawara; Miho Kaminaga; Shinpei Tatsumi
Journal:  BMJ Open       Date:  2018-07-30       Impact factor: 2.692

4.  Predictors of Inappropriate Proton Pump Inhibitors Use in Elderly Patients.

Authors:  Panagiota Voukelatou; Ioannis Vrettos; Georgia Emmanouilidou; Konstantinos Dodos; Georgia Skotsimara; Dimitra Kontogeorgou; Andreas Kalliakmanis
Journal:  Curr Gerontol Geriatr Res       Date:  2019-01-01

Review 5.  Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis.

Authors:  Sigrid Narum; Tone Westergren; Marianne Klemp
Journal:  BMJ Open       Date:  2014-05-15       Impact factor: 2.692

6.  Multimorbidities and Overprescription of Proton Pump Inhibitors in Older Patients.

Authors:  Anne Delcher; Sylvie Hily; Anne Sophie Boureau; Guillaume Chapelet; Gilles Berrut; Laure de Decker
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

7.  Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.

Authors:  Gene R Quinn; Anne S Hellkamp; Graeme J Hankey; Richard C Becker; Scott D Berkowitz; Günter Breithardt; Maurizio Fava; Keith A A Fox; Jonathan L Halperin; Kenneth W Mahaffey; Christopher C Nessel; Manesh R Patel; Jonathan P Piccini; Daniel E Singer
Journal:  J Am Heart Assoc       Date:  2018-08-07       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.